Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis (TB-HAART)
|ClinicalTrials.gov Identifier: NCT01315301|
Recruitment Status : Unknown
Verified March 2011 by Karolinska Institutet.
Recruitment status was: Recruiting
First Posted : March 15, 2011
Last Update Posted : March 15, 2011
Addis Ababa University
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||March 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Amogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A, Sonnerborg A, Aklillu E, Lindquist L. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial. PLoS One. 2015 May 12;10(5):e0122587. doi: 10.1371/journal.pone.0122587. eCollection 2015.